Jenburkt Pharmaceuticals Q2 Results
- BSE: 524731
- NSE: -
- ISIN: INE354A01013
- Sector: Biotechnology & Drugs
BSE
1,234.9
72.55 (6.24%)
72.55 (6.24%)Volume3.26 K
Updated: Mon 25 Nov, 2024 | 15:29:56
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹41.22 Cr.(26.68%)
- Operating Profit₹10.79 Cr.(22.98%)
- Profit After Tax₹9.60 Cr.(29.46%)
- Operating Margin26.17%(17.70%)
Note: Comparison is on YoY basis
Quarterly - Jenburkt Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 41.22 | 29.18 | -% | 38.29 | -% |
| Selling/ General/ Admin Expenses Total | 12.52 | 9.66 | -% | 10.89 | -% |
| Depreciation/ Amortization | 0.64 | 0.50 | -% | 0.59 | -% |
| Other Operating Expenses Total | 8.99 | 7.00 | -% | 9.09 | -% |
| Total Operating Expense | 30.43 | 22.71 | -% | 29.78 | -% |
| Operating Income | 10.79 | 6.47 | -% | 8.51 | -% |
| Net Income Before Taxes | 12.52 | 7.43 | -% | 9.54 | -% |
| Net Income | 9.60 | 5.37 | -% | 7.32 | -% |
| Diluted Normalized EPS | 21.75 | 12.17 | -% | 16.59 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST - Markets
03C2C Advanced Systems IPO Day 2: Check GMP, subscription status and other key details
2 min read06:59 PM IST